Cargando…
Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines
Small-molecule tankyrase 1 and tankyrase 2 (TNKS1/2) inhibitors are effective antitumor agents in selected tumor cell lines and mouse models. Here, we characterized the response signatures and the in-depth mechanisms for the antiproliferative effect of tankyrase inhibition (TNKSi). The TNKS1/2-speci...
Autores principales: | Mygland, Line, Brinch, Shoshy Alam, Strand, Martin Frank, Olsen, Petter Angell, Aizenshtadt, Aleksandra, Lund, Kaja, Solberg, Nina Therese, Lycke, Max, Thorvaldsen, Tor Espen, Espada, Sandra, Misaghian, Dorna, Page, Christian M., Agafonov, Oleg, Nygård, Ståle, Chi, Nai-Wen, Lin, Eva, Tan, Jenille, Yu, Yihong, Costa, Mike, Krauss, Stefan, Waaler, Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313754/ https://www.ncbi.nlm.nih.gov/pubmed/34337362 http://dx.doi.org/10.1016/j.isci.2021.102807 |
Ejemplares similares
-
Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
por: Waaler, Jo, et al.
Publicado: (2020) -
The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models
por: Brinch, Shoshy A., et al.
Publicado: (2022) -
Preclinical Lead
Optimization of a 1,2,4-Triazole
Based Tankyrase Inhibitor
por: Waaler, Jo, et al.
Publicado: (2020) -
Formation of Tankyrase Inhibitor-Induced Degradasomes Requires Proteasome Activity
por: Pedersen, Nina Marie, et al.
Publicado: (2016) -
Development of
a 1,2,4-Triazole-Based Lead Tankyrase
Inhibitor: Part II
por: Leenders, Ruben G. G., et al.
Publicado: (2021)